Back
Karyopharm Therapeutics, Inc. Stock Predictions
Still Time to Get In: RAD Intel at $0.85/Share
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Sell
24
KPTI
Karyopharm Therapeutics, Inc.
Last Price:
$5.88
Seasonality Move:
12.63%
7 Day Trial
ALL ACCESS PASS
$
7
AI Powerhouse Raises Price - But Room Remains
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radiKaryopharm Therapeutics, Inc. Stock Forecast
-
Over the next 52 weeks, Karyopharm Therapeutics, Inc. has on average historically fallen by 9.3% based on the past 12 years of stock performance.
-
Karyopharm Therapeutics, Inc. has fallen lower in 7 of those 12 years over the subsequent 52-week period, corresponding to a historical accuracy of 58.33%
-
Is Karyopharm Therapeutics, Inc. Stock Undervalued?The current Karyopharm Therapeutics, Inc. [KPTI] share price is $5.46. The Score for KPTI is 24, which is 52% below its historic median score of 50, and infers higher risk than normal.
-
KPTI is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
Will Karyopharm Therapeutics, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Karyopharm Therapeutics, Inc. has on average historically fallen by 9.3% based on the past 12 years of stock performance.
Karyopharm Therapeutics, Inc. Stock Rating
Sell
24
Karyopharm Therapeutics, Inc. (KPTI)
is a Sell
Is Karyopharm Therapeutics, Inc. overpriced?
-
Karyopharm Therapeutics, Inc. has fallen lower in 7 of those 12 years over the subsequent 52-week period, corresponding to a historical accuracy of 58.33%
Karyopharm Therapeutics, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
karyopharm.com
52-Week Data
52-Week High:
12.45
52-Week Low:
3.51
Prediction Charts
Market Cap:
93.1M
Price in USD:
5.46
Volume:
288.9K
Beta:
0.82
Technical Analysis
SMA50:
5.92
SMA100:
5.66
SMA200:
5.56
52-Wk Change:
-55.06%
Stock Predictions
-
Is Karyopharm Therapeutics, Inc. stock public?Yes, Karyopharm Therapeutics, Inc. is a publicly traded company.
-
What is the Karyopharm Therapeutics, Inc. stock quote today?The Karyopharm Therapeutics, Inc. stock price is 5.46 USD today.
-
How to buy Karyopharm Therapeutics, Inc. stock online?You can buy Karyopharm Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Nov-13 | 5.55 | 5.50 | 5.70 | 5.35 |
| Nov-14 | 5.40 | 5.68 | 5.85 | 5.40 |
| Nov-17 | 5.68 | 5.79 | 6.06 | 5.53 |
| Nov-18 | 5.73 | 6.24 | 6.43 | 5.73 |
| Nov-19 | 6.30 | 5.98 | 6.50 | 5.80 |
| Nov-20 | 6.09 | 5.76 | 6.10 | 5.70 |
| Nov-21 | 5.64 | 5.90 | 5.95 | 5.60 |
| Nov-24 | 5.88 | 5.56 | 5.93 | 5.56 |
| Nov-25 | 5.58 | 5.45 | 5.67 | 5.31 |
| Nov-26 | 5.49 | 5.55 | 5.66 | 5.37 |
| Nov-28 | 5.46 | 5.62 | 5.71 | 5.46 |
| Dec-1 | 5.60 | 5.75 | 6.15 | 5.48 |
| Dec-2 | 5.71 | 5.36 | 5.80 | 5.34 |
| Dec-3 | 5.36 | 5.46 | 5.52 | 5.30 |
Karyopharm Therapeutics, Inc. Earnings
Karyopharm Therapeutics, Inc. Earnings Report: Per Share Karyopharm Therapeutics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Karyopharm Therapeutics, Inc. Forecast Revenue Growth
Karyopharm Therapeutics, Inc. Stock Analysis: Historical quarterly revenues per share for Karyopharm Therapeutics, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $2.03 per share, a decrease next quarter of $0.00 per share, a decrease this year of $2.81 per share, and an increase next year of $7.17 per share.
* Karyopharm Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.